Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients

DOI: 10.1080/15384047.2018.1480287

Keywords: metastatic breast cancer, gene expression profile, HER2 positive, long responders, PanCancer, trastuzumab

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text